Polygenic risk of anthracycline-related cardiomyopathy in childhood cancer survivors: Report from children’s oncology group and childhood cancer survivor study.
Article
Sharafeldin, Noha, Wang, Xuexia, Wang, Fan et al. (2023). Polygenic risk of anthracycline-related cardiomyopathy in childhood cancer survivors: Report from children’s oncology group and childhood cancer survivor study.
. JOURNAL OF CLINICAL ONCOLOGY, 41(16_suppl), 12090-12090. 10.1200/jco.2023.41.16_suppl.12090
Sharafeldin, Noha, Wang, Xuexia, Wang, Fan et al. (2023). Polygenic risk of anthracycline-related cardiomyopathy in childhood cancer survivors: Report from children’s oncology group and childhood cancer survivor study.
. JOURNAL OF CLINICAL ONCOLOGY, 41(16_suppl), 12090-12090. 10.1200/jco.2023.41.16_suppl.12090